Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification

Journal of Infectious Diseases

Volumn 178, Issue 5 SUPPL., 1998, Pages 1244-1249

  Aono, Toshiya ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION RISK; MALE; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS DETECTION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MONITORING, PHYSIOLOGIC; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL;

EID: 0031782859     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314449     Document Type: Article

References (7)

1. Betts RF. Cytomegalovirus infection in transplant patients. Prog Med Virol 1982;28:44-64.
2. Meyers JD, Flournoy N, Thomas ED. Risk factors for Cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-88.
3. + cells from HLA-mismatched donors. Pediatr Infect Dis J 1998; 17:345-8.
4. Plotkin SA, Drew WL, Felsenstein D, Hirsch MS. Sensitivity of clinical isolates of human Cytomegalovirus to 9-(1,3-dihydroxy-2-propolymethyl) guanine. J Infect Dis 1985; 152:833-4.
5. Walmsley SL, Chew E, Read SE, et al. Treatment of Cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet). J Infect Dis 1988; 157:569-72.
6. Boeckh M, Stevens-Ayers T, Bowden RA. Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stern cell transplantation. J Infect Dis 1996; 174:907-12.
7. Gerna G, Zipeto D, Parea M, et al. Monitoring of human Cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 1991; 164:488-98.